U.S. markets closed
  • S&P Futures

    4,363.00
    +14.75 (+0.34%)
     
  • Dow Futures

    34,013.00
    +174.00 (+0.51%)
     
  • Nasdaq Futures

    15,048.00
    +38.50 (+0.26%)
     
  • Russell 2000 Futures

    2,186.80
    +10.00 (+0.46%)
     
  • Crude Oil

    70.90
    +0.61 (+0.87%)
     
  • Gold

    1,764.60
    +0.80 (+0.05%)
     
  • Silver

    22.27
    +0.07 (+0.32%)
     
  • EUR/USD

    1.1738
    +0.0011 (+0.09%)
     
  • 10-Yr Bond

    1.3090
    -0.0610 (-4.45%)
     
  • Vix

    25.71
    +4.90 (+23.55%)
     
  • GBP/USD

    1.3666
    +0.0007 (+0.05%)
     
  • USD/JPY

    109.5490
    +0.1290 (+0.12%)
     
  • BTC-USD

    42,702.75
    -3,558.05 (-7.69%)
     
  • CMC Crypto 200

    1,068.16
    -66.23 (-5.84%)
     
  • FTSE 100

    6,903.91
    -59.73 (-0.86%)
     
  • Nikkei 225

    29,879.07
    -620.98 (-2.04%)
     

Earnings Estimates Moving Higher for Herbalife LTD. (HLF): Time to Buy?

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Herbalife LTD. (HLF) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.

Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Herbalife LTD. Strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The earnings estimate of $0.82 per share for the current quarter represents a change of +10.81% from the number reported a year ago.

Over the last 30 days, one estimate has moved higher for Herbalife LTD. compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 12.24%.

Current-Year Estimate Revisions

For the full year, the earnings estimate of $3.75 per share represents a change of +32.98% from the year-ago number.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, one estimate has moved up for Herbalife LTD. versus no negative revisions. This has pushed the consensus estimate 11.34% higher.

Favorable Zacks Rank

Thanks to promising estimate revisions, Herbalife LTD. currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

Investors have been betting on Herbalife LTD. because of its solid estimate revisions, as evident from the stock's 6.1% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Herbalife LTD. (HLF) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research